OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for interchangeability was supported by positive phase III data demonstrating comparable ...

High blood pressure, or hypertension, is a common condition that affects millions of people worldwide. To prevent serious ...

A health watchdog has received hundreds of reports over the past 13 months of Scots who have fallen ill after injecting ...

A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, ...

Parents and pediatricians just gained one more tool to combat severe allergic reactions in young kids. San Diego-based ARS ...

The U.S. Food and Drug Administration approved the expanded use of ARS Pharmaceuticals' nasal spray for severe allergic ...

A stepfather in Kentucky will now spend 25 years in prison for the death of an 8-year-old boy who died after what officials ...

and unless a person is experiencing an unmanageable adverse reaction or side effects, healthcare providers usually give a trial of four weeks or longer before suggesting a different medication or ...

CBD may possess many therapeutic uses and benefits. However, as with any drug, some people may experience side effects when using products containing CBD. In 2017, the World Health Organization ...

He was revived, but died in hospital the following day. His cause of death was recorded as anaphylaxis, a serious allergic reaction that causes inflammation of the airways. The case has been ...